GlassScriptPhysician profile
Emma O'Neil
NPI 1154913150
$1,393.28
in general payments reported to CMS, 2019-2025
22 companies · $705 in 2025
The $705 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.39 · 2022: $115 · 2023: $324 · 2024: $227 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.59 | 2022-2024 | |
| Bioventus LLC | $133.35 | 2022-2024 | Durolane |
| Medtronic, INC. | $98.18 | 2025 | Minimed 780g |
| Novo Nordisk INC | $73.47 | 2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $72.91 | 2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $68.34 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Depuy Synthes Sales INC. | $66.08 | 2023-2024 | Monovisc, Orthovisc, Peak |
| Sequel Med Tech, LLC | $64.97 | 2025 | Twiist |
| Lilly USA, LLC | $62.69 | 2025 | Zepbound, Jardiance, Mounjaro |
| Vertos Medical, INC. | $50.18 | 2022-2024 | Mild Device Kit |
| Amneal Pharmaceuticals LLC | $46.74 | 2025 | Unithroid |
| Amgen INC. | $43.03 | 2025 | Prolia, Evenity |
| Mannkind Corporation | $32.70 | 2025 | |
| Stryker Corporation | $29.09 | 2025 | Mild Device Kit |
| Spr Therapeutics, INC | $28.57 | 2023 | Sprint Pns System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $26.70 | 2025 | Hyrimoz |
| Xeris Pharmaceuticals, INC. | $24.60 | 2025 | Gvoke Hypopen |
| Allergan, INC. | $22.39 | 2021 | |
| Almatica Pharma LLC | $21.40 | 2025 | Teriparatide |
| Corcept Therapeutics | $20.88 | 2025 | Korlym |
| Acella Pharmaceuticals, LLC | $19.32 | 2025 | NP Thyroid 60 |
| Scilex Pharmaceuticals INC. | $17.10 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma O'Neil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.